M Maral Mouradian Selected Research

Transglutaminases

2/2003

Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Maral Mouradian Research Topics

Disease

37	Parkinson Disease (Parkinson's Disease) 02/2024 - 03/2002
12	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 06/2002
12	Synucleinopathies 08/2021 - 08/2009
7	Dementia (Dementias) 02/2024 - 02/2003
6	Dyskinesias (Dyskinesia) 12/2021 - 05/2010
5	Neuroinflammatory Diseases 01/2020 - 01/2012
3	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 02/2003
3	Huntington Disease (Huntington's Disease) 02/2024 - 06/2002
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2013 - 07/2006
1	Cognitive Dysfunction 02/2024
1	Disease Progression 10/2021
1	Ischemic Stroke 01/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Tauopathies 01/2018
1	Parkinsonian Disorders (Parkinsonism) 06/2015
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2014
1	Hypersensitivity (Allergy) 05/2010
1	Neuroblastoma 05/2009
1	Inflammation (Inflammations) 07/2006
1	Amyloid Plaque 07/2006
1	Multiple System Atrophy 02/2003
1	Brain Neoplasms (Brain Tumor) 07/2002
1	Multiple Sclerosis 07/2002
1	Central Nervous System Diseases (CNS Diseases) 07/2002
1	Nervous System Diseases (Neurological Disorders) 07/2002
1	Viral Encephalitis 07/2002
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 05/2002

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
16	SynucleinsIBA 02/2024 - 05/2011
6	Levodopa (L Dopa)FDA LinkGeneric 12/2021 - 05/2010
6	alpha-SynucleinIBA 11/2019 - 03/2002
5	MicroRNAs (MicroRNA)IBA 01/2020 - 05/2010
4	Protein Glutamine gamma Glutamyltransferase 2IBA 02/2024 - 02/2003
4	Dopamine (Intropin)FDA LinkGeneric 10/2019 - 06/2003
3	Amyloid (Amyloid Fibrils)IBA 02/2024 - 01/2018
3	Protein AggregatesIBA 02/2024 - 07/2006
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2016 - 05/2011
3	polyglutamineIBA 04/2008 - 05/2002
2	Glucosylceramidase (Glucocerebrosidase)IBA 02/2024 - 01/2022
2	MAP Kinase Kinase Kinase 5IBA 01/2020 - 01/2015
2	Coffee FDA Link 12/2018 - 01/2013
2	Caffeine (No Doz)FDA LinkGeneric 12/2018 - 01/2013
2	eicosanoyl-5-hydroxytryptamideIBA 12/2018 - 01/2013
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018 - 10/2016
2	AntioxidantsIBA 01/2015 - 07/2012
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2013 - 01/2012
1	Intrinsically Disordered ProteinsIBA 01/2024
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Nucleic AcidsIBA 01/2019
1	MethyltransferasesIBA 01/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	EnzymesIBA 01/2018
1	Narcotic Antagonists (Opioid Antagonists)IBA 06/2015
1	Nalbuphine (Nubain)FDA LinkGeneric 06/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015
1	CalciumIBA 01/2013
1	IronIBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	perampanelIBA 02/2012
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 02/2012
1	Serine (L-Serine)FDA Link 05/2011
1	Hormones (Hormone)IBA 05/2009
1	SteroidsIBA 05/2009
1	LuciferasesIBA 05/2009
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 05/2009
1	Estrogen ReceptorsIBA 05/2009
1	PhosphoproteinsIBA 02/2004
1	TransglutaminasesIBA 02/2003
1	epsilon-(gamma-glutamyl)-lysineIBA 02/2003
1	Complementary DNA (cDNA)IBA 07/2002
1	Interferon-betaIBA 07/2002
1	Huntingtin ProteinIBA 06/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2010
3	Deep Brain Stimulation 02/2024 - 01/2022
1	Cell Transplantation 06/2003